Related Experiment Videos
Bispecific antibodies for targeted cellular cytotoxicity
1Department of Microbiology, Dartmouth Medical School, Hanover, NH.
Trends in Biotechnology
|November 1, 1991
Summary
Bispecific antibodies redirect natural immune responses to target and eliminate cancerous tumors and infectious pathogens. This dual-targeting capability offers a promising therapeutic strategy for treating cancer and various infectious diseases.
Area of Science:
- Immunology
- Oncology
- Infectious Diseases
Background:
- Bispecific antibodies are engineered proteins with the capacity to bind to two different antigens simultaneously.
- They offer a unique mechanism for engaging the immune system against targeted cells.
Purpose of the Study:
- To explore the therapeutic potential of bispecific antibodies.
- To highlight their role in redirecting cytotoxic mechanisms for disease treatment.
Main Methods:
- Review of existing literature on bispecific antibody technology.
- Analysis of preclinical and clinical data regarding efficacy and safety.
Main Results:
- Bispecific antibodies effectively redirect cytotoxic T-lymphocytes and other immune cells to tumor cells.
- Demonstrated efficacy in targeting various pathogens, including viruses and bacteria.
- Potential for overcoming resistance mechanisms in cancer therapy.
Conclusions:
- Bispecific antibodies represent a powerful and versatile therapeutic modality.
- They hold significant promise for the treatment of both cancer and infectious diseases.